NCT01638858View on ClinicalTrials.gov

Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2014

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

Lucentis (Ranibizumab)

Ranibizumab Short- and Log-term Effects on Retinal Function measured by Multifocal-ERG and Microperimetry

Trial Locations (1)

Unknown

University of Luebeck - Department of Ophthalmology, Lübeck

All Listed Sponsors
lead

University of Luebeck

OTHER

NCT01638858 - Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis) | Biotech Hunter | Biotech Hunter